Clinical Trial Update: Continuation of Antiarrhythmics Following Ventricular Tachycardia Catheter Ablation [Phase 3]

View source ↗

Summary

A Phase 3 trial studying continuation of antiarrhythmic therapy after ventricular tachycardia catheter ablation was terminated; results posted in 2022.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ventricular Tachycardia

Snippet

Sponsor: Vanderbilt University Medical Center | Conditions: Tachycardia, Ventricular, Catheter Ablation | Phase 3 | Status: TERMINATED | Results posted: 2022-11-14